These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9415568)

  • 41. Fibrinolytic system in adolescents: response to venous occlusion stress tests.
    Monagle P; Chan AK; Albisetti M; Vegh P; Andrew M; Mitchell L
    Pediatr Res; 2003 Feb; 53(2):333-7. PubMed ID: 12538795
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma tissue-type plasminogen activator, fibrinogen, and time on dialysis prior to transplantation are related to carotid intima media thickness in renal transplant recipients.
    Brzosko S; Hryszko T; Lebkowska U; Malyszko J; Malyszko JS; Mysliwiec M
    Transplant Proc; 2003 Dec; 35(8):2931-4. PubMed ID: 14697941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibrinolysis defect in long-term hemodialysis patients with type 2 diabetes mellitus and its relation to metabolic disorders.
    Opatrný K; Zemanová P; Mares J; Vít L; Opatrná S; Sefrna F; Hejda V; Tomsů M; Eiselt J; Massry SG
    Am J Nephrol; 2002; 22(5-6):429-36. PubMed ID: 12381940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
    Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus.
    Jain A; Kashyap R; Marsh W; Rohal S; Khanna A; Fung JJ
    Transplantation; 2001 Apr; 71(8):1102-6. PubMed ID: 11374410
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
    Orbe J; Chordá C; Montes R; Páramo JA
    Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrinolytic activity in multiple myeloma.
    Yağci M; Sucak GT; Haznedar R
    Am J Hematol; 2003 Dec; 74(4):231-7. PubMed ID: 14635202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fibrinolytic system in bronchial asthma after prednisone treatment].
    Banach-Wawrzeńczyk E; Dziedziczko A; Rość D
    Pol Merkur Lekarski; 2000 Jan; 7(43):9-11. PubMed ID: 10765644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of blood passage through the pulmonary circulation on fibrinolytic parameters.
    Kloboves-Prevodnik V; Sabovic M; Keber D
    Heart Vessels; 2004 Jan; 19(1):33-7. PubMed ID: 14685753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients. An immunocytochemical study.
    Labarrere CA; Pitts D; Halbrook H; Faulk WP
    Circulation; 1994 Apr; 89(4):1599-608. PubMed ID: 8149527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
    Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
    Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibrinolytic activity in laparoscopic cholecystectomy.
    Martinez-Ramos C; Lopez-Pastor A; Núñez-Peña JR; Ruiz-Caravaca ML; Ruiz de Gopegui M; Sanz-López R; Jorgensen TW; Tamames-Escobar S
    J Laparoendosc Adv Surg Tech A; 1998 Dec; 8(6):417-23. PubMed ID: 9916595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].
    Tkaczyk M; Owczarek D; Finke D; Nowicki M
    Pol Merkur Lekarski; 2003 Apr; 14(82):315-8. PubMed ID: 12868191
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Clin Exp Nephrol; 2007 Jun; 11(2):151-155. PubMed ID: 17593515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.
    Crowther MA; Roberts J; Roberts R; Johnston M; Stevens P; Skingley P; Patrassi GM; Sartori MT; Hirsh J; Prandoni P; Weitz JI; Gent M; Ginsberg JS
    Thromb Haemost; 2001 Mar; 85(3):390-4. PubMed ID: 11307802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thrombin activatable fibrinolysis inhibitor in hypertensive kidney transplant recipients.
    Malyszko J; Malyszko JS; Hryszko T; Mysliwiec M
    Transplant Proc; 2006; 38(1):105-7. PubMed ID: 16504676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of cyclosporine MEPC (Neoral) in heart transplant recipients.
    Fukushima N; Ohtake S; Sawa Y; Nishimura M; Kobayashi Y; Shirakura R; Nakata S; Matsuda H
    Transplant Proc; 1998 Nov; 30(7):3337-8. PubMed ID: 9838473
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.